Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Cyclerion Therapeutics (CYCN) Accumulated Depreciation & Amortization (2019 - 2022)

Historic Accumulated Depreciation & Amortization for Cyclerion Therapeutics (CYCN) over the last 4 years, with Q4 2022 value amounting to $2.2 million.

  • Cyclerion Therapeutics' Accumulated Depreciation & Amortization fell 86.36% to $2.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.2 million, marking a year-over-year decrease of 86.36%. This contributed to the annual value of $2.2 million for FY2022, which is 86.36% down from last year.
  • Cyclerion Therapeutics' Accumulated Depreciation & Amortization amounted to $2.2 million in Q4 2022, which was down 86.36% from $2.3 million recorded in Q3 2022.
  • Over the past 5 years, Cyclerion Therapeutics' Accumulated Depreciation & Amortization peaked at $31.0 million during Q3 2019, and registered a low of $2.1 million during Q2 2021.
  • Its 4-year average for Accumulated Depreciation & Amortization is $11.9 million, with a median of $6.3 million in 2020.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 2935.63% in 2020, then crashed by 9001.8% in 2021.
  • Quarter analysis of 4 years shows Cyclerion Therapeutics' Accumulated Depreciation & Amortization stood at $21.6 million in 2019, then plummeted by 52.38% to $10.3 million in 2020, then plummeted by 78.61% to $2.2 million in 2021, then fell by 0.86% to $2.2 million in 2022.
  • Its Accumulated Depreciation & Amortization was $2.2 million in Q4 2022, compared to $2.3 million in Q3 2022 and $2.3 million in Q2 2022.